Current and future therapeutic options for chronic hepatitis D virus infection
Mariantonietta Pisaturo(University of Antwerp), Nicola Coppola(University of Campania "Luigi Vanvitelli"), Pierantonio Grimaldi(University of Campania "Luigi Vanvitelli"), Salvatore Martini(University of Campania "Luigi Vanvitelli")
Cited by 5
Related Papers
Mortality Attributable to Bloodstream Infections Caused by Different Carbapenem-Resistant Gram-Negative Bacilli: Results From a Nationwide Study in Italy (ALARICO Network)
|Clinical Infectious Diseases|2023|156
Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients
|Diabetes & Metabolism|2020|138
Anticoagulant treatment in COVID-19: a narrative review
|Journal of Thrombosis and Thrombolysis|2020|111
Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories
|Journal of Hepatology|2023|94
Clinical significance of hepatitis B surface antigen mutants
|World Journal of Hepatology|2015|87